VIROPHARMA INC
VPHM
VPHM was delisted on the 23rd of January, 2014.
191 hedge funds and large institutions have $2.87B invested in VIROPHARMA INC in 2013 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 63 increasing their positions, 69 reducing their positions, and 19 closing their positions.
105% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 19
45% more capital invested
Capital invested by funds: $1.98B → $2.87B (+$896M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
10% more funds holding
Funds holding: 174 → 191 (+17)
6% less call options, than puts
Call options by funds: $72.1M | Put options by funds: $76.7M
9% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 69
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$137M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$119M |
| 3 |
PC
PointState Capital
New York
|
+$43.1M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
+$40.9M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$40.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$96M |
| 2 |
SCM
Scopia Capital Management
New York
|
-$39.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$33.3M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$31.5M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$28.6M |
VPHM Hedge Fund Activity: Q3 2013 in Review
191 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in VIROPHARMA INC (VPHM) for Q3 2013, worth a combined $2.87B — up 45% from $1.98B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new VPHM positions and 19 closed out — a net gain of 20 holders — while 63 added to existing stakes and 69 trimmed.
The largest buyer was Westfield Capital Management, adding an estimated $137M. The largest seller was Baker Bros. Advisors, cutting an estimated $96M.
- 191 institutional investors held VIROPHARMA INC (VPHM) as of Q3 2013, up from 174 in Q2 2013.
- Funds reported $2.87B of VIROPHARMA INC stock for Q3 2013, up 45% quarter-over-quarter.
- 39 funds opened new VIROPHARMA INC positions in Q3 2013 and 19 closed out, a net change of +20 holders.
- The largest VIROPHARMA INC buyer in Q3 2013 was Westfield Capital Management, an estimated $137M added.
- The largest VIROPHARMA INC seller in Q3 2013 was Baker Bros. Advisors, an estimated $96M sold.
Based on aggregated 13F filings for Q3 2013.